A Revolutionary Medical App Powered by AI

A revolutionary medical app powered by AI that presents an incredible opportunity. With a 2 to 1 potential return in 36-48 months and a strong first-year tax benefit return of over 150%, the company is a cutting-edge healthcare app that integrates with smartphones and wearable devices like the Apple Watch or Fitbit. By focusing on promoting Well Care rather than sick care, the app reduces healthcare costs and improves patient outcomes.

The development team has dedicated three years to crafting and refining this app, ensuring its quality and potential for success. The app's architect and visionary have a successful track record winning 25 top industry awards and in building and selling software companies.

The company targets insurance companies, healthcare networks, and large medical practices as its primary customers. Sales presentations have already yielded positive responses, and we anticipate generating over $1 million in annualized revenue by December, with monthly revenue reaching $1 million by the second quarter of 2024.

The company's team already maintains close relationships with medical practices serving over 150,000 patients. With just 60,000 patients signed up, we can generate an estimated $17 million in annual revenue, making the company worth approximately $95.2 million based on a 5.6 multiple on revenue. Moreover, our marketing team has the potential to establish new relationships and drive further growth. The company conservatively estimates an exit value of over $100 million within 36-48 months.

Investing in the company offers potential investors three key benefits: 2 to 1 Return on Capital: Once we have 60,000 patient customers or more, we expect to sell the app to a larger company for $95 million or more, resulting in greater than a 2 to 1 return on capital within 36-48 months.
There will be a 6% Per Annum Dividend: Investors will receive a 6% per annum dividend payable quarterly starting from day 1. There is a 150-180% Return via Tax Code: Through bonus depreciation, investors can potentially receive a return of 150-180% in 3-12 months, depending on their tax bracket.

In this investment structure, the software is eligible for bonus depreciation, which allows for significant tax savings. For example, an investor making a $100,000 investment can buy a $500,000 Right To Use (RTU) contract in the software and can expect first-year tax savings of $180,600 (based on a 43% tax rate). These tax benefits result in a 155-180% return on the investment in the first year*.

The company presents an exciting opportunity for investors. With its innovative approach to healthcare and potential for impressive returns, investing in the opportunity is a smart decision.

Don't miss out on this unique tax-efficient investment opportunity.

Any investment should be considered speculative and contains inherent risks including but not limited to the loss of some or all of your investment. This investment is not a sale of securities but rather an investment in the right-to-use (RTU) software in the form of a loan which is repaid with interest over time. This investment is restricted to accredited investors only.